The Latest Non-Redemption Agreements: May 19, 2023
by Marlena Haddad on 2023-05-19 at 5:33pm

Latest Non-Redemption Agreements:  Capitalworks Emerging Markets, and GSR II Meteora


Capitalworks Emerging Markets (CMCA) Adds Non-Redemption Agreement

On May 18, 2023, Capitalworks Emerging Markets Acquisition Corp. (NASDAQ:CMCA) and the Company’s sponsor, CEMAC Sponsor LP, entered into additional non-redemption agreements with certain unaffiliated third parties in exchange for the Holder or Holders agreeing either not to request redemption, or to reverse any previously submitted redemption demand with respect to certain Class A ordinary shares.

In consideration of the foregoing agreement, immediately prior to, and substantially concurrently with, the closing of an initial business combination, the Sponsor will surrender and forfeit to the company for no consideration certain Class B ordinary shares and the company shall issue to the Holders a number of Class A ordinary shares equal to the Forfeited Shares.

As of the date of this report, CMCA has entered into Non-Redemption Agreements with respect to an aggregate of 4,000,000 Class A ordinary shares, and has agreed to issue an aggregate of 1,000,000 Class A ordinary shares while the Sponsor has agreed to surrender and forfeit an aggregate of 1,000,000 Forfeited Shares for no consideration immediately prior to, and substantially concurrently with, the closing of an initial business combination.

READ

GSR II Meteora Acquisition Corp. (GSRM) Adds Non-Redemption Agreement

On May 18, 2023, GSR II Meteora Acquisition Corp. (NASDAQ:GSRM) entered into voting and non-redemption agreements with unaffiliated third parties in exchange for such Non-Redeeming Stockholders agreeing to either not redeem or to reverse any previously submitted redemption request with respect to an aggregate of 6,033,000 shares of the Company’s Class A common stock.

In exchange for the foregoing commitments not to redeem such Non-Redeemed Shares, the company has agreed to issue to the Non-Redeeming Stockholders an aggregate of 60,330 shares of the Company’s Class A common stock.

If the Extension Proposal is approved, the Non-Redeeming Stockholders shall be entitled to receive up to 120,660 shares of Class A common stock in connection with the Initial Extension and for each Monthly Extension that occurs prior to the closing of an initial business combination.

READ

 

The Latest Non-Redemption Agreements: May 19, 2023
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved